Cerenis raises EUR 40 million

Cerenis Therapeutics S.A. (Labege, France) raised EUR 40 million ($51.7 million) in a first close of a planned series C round of up to EUR 50 million ($64.6 million) led by new investor Fonds Stratégique d Investissement (FSI). Existing investors Sofinnova Partners; HealthCap; Alta Partners; TVM Capital; EDF Ventures; OrbiMed Advisors; and Daiwa Bank Investment also participated. The second and final close is expected by year end.

FSI representative Jean-Pierre Garnier will join Cerenis' board. Garnier is the former CEO of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and Laboratoires Pierre Fabre S.A. (Castres, France). ...